公开(公告)号：US20110212095A1

公开(公告)日：2011-09-01

申请号：US12868811

申请日：2010-08-26

申请人： Hyung-Geun SONG ,  Sang-Sun Yoon ,  Mi-Hyang Shin ,  Yu-Ri Moon

发明人： Hyung-Geun SONG ,  Sang-Sun Yoon ,  Mi-Hyang Shin ,  Yu-Ri Moon

IPC分类号： A61K39/395 ,  C07K7/08 ,  C07K16/30 ,  C12N5/16 ,  G01N33/574 ,  A61P35/00

CPC分类号： G01N33/57423 ,  A61K2039/505 ,  C07K14/70503 ,  C07K16/2803 ,  C07K16/30 ,  C07K2317/34 ,  C07K2319/30

摘要： The present invention relates to epitope of CD66c specific to lung adenocarcinoma and antibody recognizing the same. The present invention relates to identifying epitope of CD66c specific to lung adenocarcinoma, antibody recognizing the same, cell lines producing the same and the applications in diagnosis, prevention and treatment of lung adenocarcinoma by using the same. The above CD66c epitope is specific to lung adenocarcinoma cells, and therefore the antibody or its fragment recognizing the epitope can be used in compositions to diagnose, treat and prevent lung adenocarcinoma cells.

摘要翻译： 本发明涉及肺腺癌特异性的CD66c表位和识别其的抗体。 本发明涉及鉴定肺腺癌特异性的CD66c表位，识别其的抗体，产生该抗体的细胞系以及通过使用该腺癌诊断，预防和治疗肺腺癌的应用。 上述CD66c表位对肺腺癌细胞是特异性的，因此识别表位的抗体或其片段可用于诊断，治疗和预防肺腺癌细胞的组合物中。

公开(公告)号：US08404812B2

公开(公告)日：2013-03-26

申请号：US12868811

申请日：2010-08-26

申请人： Hyung-Geun Song ,  Sang-Sun Yoon ,  Mi-Hyang Shin ,  Yu-Ri Moon

发明人： Hyung-Geun Song ,  Sang-Sun Yoon ,  Mi-Hyang Shin ,  Yu-Ri Moon

IPC分类号： C07K16/00 ,  C12N5/07 ,  G01N33/53 ,  A61K39/395

CPC分类号： G01N33/57423 ,  A61K2039/505 ,  C07K14/70503 ,  C07K16/2803 ,  C07K16/30 ,  C07K2317/34 ,  C07K2319/30

摘要： The present invention relates to epitope of CD66c specific to lung adenocarcinoma and antibody recognizing the same. The present invention relates to identifying epitope of CD66c specific to lung adenocarcinoma, antibody recognizing the same, cell lines producing the same and the applications in diagnosis, prevention and treatment of lung adenocarcinoma by using the same. The above CD66c epitope is specific to lung adenocarcinoma cells, and therefore the antibody or its fragment recognizing the epitope can be used in compositions to diagnose, treat and prevent lung adenocarcinoma cells.

摘要翻译： 本发明涉及肺腺癌特异性的CD66c表位和识别其的抗体。 本发明涉及鉴定肺腺癌特异性的CD66c表位，识别其的抗体，产生该抗体的细胞系以及通过使用该腺癌诊断，预防和治疗肺腺癌的应用。 上述CD66c表位对肺腺癌细胞是特异性的，因此识别表位的抗体或其片段可用于诊断，治疗和预防肺腺癌细胞的组合物中。